ICYMI: LAWMAKERS MAKE BIPARTISAN CALL FOR FURTHER ACTION TO CRACK DOWN ON BIG PHARMA’S PATENT THICKETS
Mar 28, 2023
Members of Congress Send Letter Encouraging USPTO to Close Loopholes Exploited… Read More
© 2026 CSRXP- All Rights Reserved
ICYMI
ICYMI: I-MAK: Cracking Down on Big Pharma’s Patent Abuse to Lower Drug Prices Should Be Bipartisan Priority
Jan 27, 2023
Non-Profit Advocates for Affordable Prescription Drug Prices Call on Congress… Read More
ICYMI: STUDY FINDS MEDICARE PART B WOULD HAVE SAVED $3.7 BILLION OVER THREE YEARS IF BIG PHARMA’S PRICE HIKES WERE BELOW THE RATE OF INFLATION
Jan 9, 2023
Analysis Finds Drug Companies Increased Prices Faster Than the Rate of… Read More
ICYMI: WHAT COMES NEXT AFTER MAJOR STEP FORWARD ON DRUG PRICING
Sep 19, 2022
What Comes Next After Major Step Forward on Drug Pricing Real Clear Health… Read More
ICYMI: OPINION: DRUG COMPANIES ARE WARNING THAT PRICING REFORM SPELLS DOOM. DON’T FALL FOR IT
Aug 8, 2022
Washington Post Op-ed Debunks Bogus Big Pharma Claims That Solutions to Lower… Read More
ICYMI: CIVICASCRIPT BRINGS FIRST GENERIC DRUG TO MARKET TO PROVIDE MORE AFFORDABLE ALTERNATIVE TO HIGH-PRICED BIG PHARMA PRODUCTS
Aug 3, 2022
Private Sector and Non-Profit Partners Introduce Cancer Treatment That Can… Read More
ICYMI: USPTO, FDA ANNOUNCE PLAN TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Jul 19, 2022
Joint Effort Aims to Curb Anti-Competitive Tactics Used by Brand Name Drug… Read More
ICYMI: CBO FINDS HOLDING BIG PHARMA ACCOUNTABLE FOR ANTI-COMPETITIVE TACTICS WOULD SAVE BILLIONS OF DOLLARS
Jun 8, 2022
Scoring Shows Solutions to Crack Down on Branded Drug Companies’… Read More
ICYMI: ANALYSIS REVEALS IMPACT OF BIG PHARMA’S ANTI-COMPETITIVE PRACTICES AROUND INHALERS
May 18, 2022
Brand Name Drug Companies Prevent Competition from More Affordable… Read More
ICYMI: NEW SURVEY FINDS VOTERS CONTINUE TO BLAME BIG PHARMA FOR OUT-OF-CONTROL DRUG PRICES, SUPPORT CONGRESSIONAL ACTION
Apr 27, 2022
Patients for Affordable Drugs Now Poll Finds Vast Majority of Voters Reject… Read More
ICYMI: THE NEW YORK TIMES EDITORIAL BOARD ENDORSES SOLUTIONS TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Apr 18, 2022
Highlights How Administration and Lawmakers Can Fix Loopholes Exploited by… Read More
ICYMI: HEALTH CARE LEADERS LAUNCH LOW-COST INSULIN INITIATIVE
Mar 7, 2022
Non-Profit and Private Sector Partners Work Together to Help Provide Relief… Read More